A carboplatin shortage or cisplatin shortage does not mean mesothelioma treatment has to stop. The standard chemotherapy for pleural mesothelioma can be given with either platinum drug, and immunotherapy regimens that use no platinum drug at all are now standard options for many patients. Shortages are still worth a direct conversation with your oncologist, because the right adjustment depends on your situation.
At Throneberry Law Group, we help people harmed by asbestos pursue compensation, and we also pay attention to the treatment problems our clients face. Michael Throneberry lost his father-in-law to mesothelioma, so questions about access to care are not abstract for us. Treatment decisions belong with your medical team, and our chemotherapy for mesothelioma page explains the basics so you can ask better questions.
What Caused the Platinum Chemotherapy Shortage
The 2023 shortage began when a quality inspection shut down production at one manufacturer. According to a Food and Drug Administration presentation from June 2023, the cisplatin shortage pushed demand onto carboplatin, and manufacturers could not meet it. The FDA estimated that up to 500,000 patients might need a platinum drug during that period.
Shortages of this kind can recur whenever a few plants supply most of a generic drug. That is why patients starting treatment sometimes hear that a medication is limited and wonder whether their plan is at risk.
Does Mesothelioma Treatment Have More Than One Chemotherapy Option
Yes. The usual first-line chemotherapy for pleural mesothelioma combines pemetrexed with a platinum drug, and either cisplatin or carboplatin can fill that role. If one is unavailable, an oncologist can consider the other when it is appropriate for the patient, which is how many cancer centers responded during the 2023 shortage.
That flexibility means a shortage of one drug rarely forces treatment to stop. Your doctor weighs your kidney function, overall health, and other factors when choosing between the two. Our mesothelioma treatment overview describes how chemotherapy fits with surgery and radiation.
Can Immunotherapy Replace Platinum Chemotherapy
For some patients it can. The National Cancer Institute lists nivolumab and ipilimumab among the immunotherapy drugs used for advanced mesothelioma, and that combination uses no platinum chemotherapy. For patients who cannot tolerate pemetrexed because of poor kidney function, it is already a common choice. The American Society of Clinical Oncology’s 2025 pleural mesothelioma guideline update also lists pembrolizumab combined with pemetrexed and a platinum drug as a first-line option for patients with the epithelioid cell type, so a center working around a shortage has more than one guideline-backed path to choose from.
What That Means During a Shortage
If platinum drugs are scarce, a non-platinum immunotherapy regimen may give your care team a path that avoids the shortage entirely. Whether it fits depends on the type of mesothelioma, how far it has spread, and your other health conditions. Our post on the benefits of immunotherapy for mesothelioma covers how these drugs work.
Side Effects Still Matter
Switching drugs can change the side effects you experience. Our post on managing chemotherapy side effects covers the most common ones and when to call your doctor.
What Should You Do If Your Center Reports a Shortage
Ask your oncologist directly whether the shortage affects your plan, and do not change anything on your own. Depending on your circumstances, your care team may consider:
- Using the available platinum drug: Switching between cisplatin and carboplatin when medically appropriate.
- Adjusting within approved ranges: Changing dose or schedule inside established guidelines.
- Changing the timing: Shifting a cycle while supply catches up.
- Choosing an immunotherapy regimen: Using a non-platinum option when it fits your diagnosis.
The right answer depends on the specific shortage, your stage and cell type, your current plan, and your oncologist’s judgment. Our mesothelioma diagnosis page explains the staging and cell-type details that drive those choices.
Nationwide Mesothelioma Lawyers at Throneberry Law Group
Every disruption in treatment adds stress and often adds cost, and if asbestos exposure caused your mesothelioma, the companies responsible may be made to pay for your care. Throneberry Law Group investigates where and how exposure happened, identifies the manufacturers involved, and pursues compensation through lawsuits and trust claims for clients across the country.
If you or a family member is facing mesothelioma treatment, we can review your situation at no cost while you focus on your health. Reach our team through our contact form for a free consultation.
